Figure 1From: External validation of risk classification in patients with docetaxel-treated castration-resistant prostate cancer Waterfall plots of prostate-specific antigen (PSA) responses according to total (a), good-(b), intermediate-(c), and poor-(d) risk group of Armstrong risk classification. Back to article page